• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy.SLC37A4-CDG:一种新兴的伴发严重凝血障碍的糖基化先天性疾病的新生化见解。
Clin Chim Acta. 2021 Oct;521:104-106. doi: 10.1016/j.cca.2021.07.005. Epub 2021 Jul 8.
2
A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.SLC37A4 中的突变导致一种显性遗传的糖基化先天性疾病,其特征为肝功能障碍。
Am J Hum Genet. 2021 Jun 3;108(6):1040-1052. doi: 10.1016/j.ajhg.2021.04.013. Epub 2021 May 7.
3
Serum bikunin isoforms in congenital disorders of glycosylation and linkeropathies.血清 bikunin 同种型在糖基化障碍和连接蛋白病中的变化。
J Inherit Metab Dis. 2020 Nov;43(6):1349-1359. doi: 10.1002/jimd.12291. Epub 2020 Aug 7.
4
Biochemical diagnosis of congenital disorders of glycosylation.先天性糖基化障碍的生化诊断。
Adv Clin Chem. 2024;120:1-43. doi: 10.1016/bs.acc.2024.03.001. Epub 2024 Apr 16.
5
Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation.先天性糖基化障碍。第一部分。蛋白质N-糖基化缺陷。
Acta Biochim Pol. 2013;60(2):151-61. Epub 2013 May 31.
6
Genetic defects in dolichol metabolism.多萜醇代谢中的遗传缺陷。
J Inherit Metab Dis. 2015 Jan;38(1):157-69. doi: 10.1007/s10545-014-9760-1. Epub 2014 Oct 1.
7
SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals.SLC35A2-CDG:30 例未经报道个体的功能特征、扩展的分子、临床和生化表型。
Hum Mutat. 2019 Jul;40(7):908-925. doi: 10.1002/humu.23731. Epub 2019 Apr 24.
8
Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis.在小鼠中模拟人类IIa型先天性糖基化障碍:哺乳动物生理学中依赖天冬酰胺连接聚糖的功能的保守性以及对疾病发病机制的见解
Glycobiology. 2001 Dec;11(12):1051-70. doi: 10.1093/glycob/11.12.1051.
9
Deficient glycan extension and endoplasmic reticulum stresses in ALG3-CDG.ALG3-CDG 中聚糖延伸和内质网应激不足。
J Inherit Metab Dis. 2024 Jul;47(4):766-777. doi: 10.1002/jimd.12739. Epub 2024 Apr 10.
10
Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!科姆罗尔讲座。先天性糖基化障碍(CDG):全在于此!
J Inherit Metab Dis. 2003;26(2-3):99-118. doi: 10.1023/a:1024431131208.

引用本文的文献

1
Diagnostic and Therapeutic Approaches in Congenital Disorders of Glycosylation.先天性糖基化障碍的诊断与治疗方法
Handb Exp Pharmacol. 2025;288:211-241. doi: 10.1007/164_2025_745.
2
Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2021-2022.基质辅助激光解吸/电离质谱法分析碳水化合物和糖缀合物:2021 - 2022年最新进展
Mass Spectrom Rev. 2025 May-Jun;44(3):213-453. doi: 10.1002/mas.21873. Epub 2024 Jun 24.

本文引用的文献

1
MAN1B1-CDG: Three new individuals and associated biochemical profiles.曼-1B1型先天性糖基化障碍:三名新患者及相关生化特征
Mol Genet Metab Rep. 2021 Jun 2;28:100775. doi: 10.1016/j.ymgmr.2021.100775. eCollection 2021 Sep.
2
A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.SLC37A4 中的突变导致一种显性遗传的糖基化先天性疾病,其特征为肝功能障碍。
Am J Hum Genet. 2021 Jun 3;108(6):1040-1052. doi: 10.1016/j.ajhg.2021.04.013. Epub 2021 May 7.
3
SLC37A4-CDG: Second patient.SLC37A4 - 先天性糖基化障碍:第二位患者。
JIMD Rep. 2021 Jan 6;58(1):122-128. doi: 10.1002/jmd2.12195. eCollection 2021 Mar.
4
SLC37A4-CDG: Mislocalization of the glucose-6-phosphate transporter to the Golgi causes a new congenital disorder of glycosylation.SLC37A4 - 先天性糖基化障碍:葡萄糖 - 6 - 磷酸转运体在高尔基体的定位错误导致一种新的先天性糖基化障碍。
Mol Genet Metab Rep. 2020 Aug 21;25:100636. doi: 10.1016/j.ymgmr.2020.100636. eCollection 2020 Dec.
5
Serum bikunin isoforms in congenital disorders of glycosylation and linkeropathies.血清 bikunin 同种型在糖基化障碍和连接蛋白病中的变化。
J Inherit Metab Dis. 2020 Nov;43(6):1349-1359. doi: 10.1002/jimd.12291. Epub 2020 Aug 7.
6
CDG biochemical screening: Where do we stand?CDG 生化筛查:我们处于什么位置?
Biochim Biophys Acta Gen Subj. 2020 Oct;1864(10):129652. doi: 10.1016/j.bbagen.2020.129652. Epub 2020 Jun 5.
7
Use of Endoglycosidase H as a diagnostic tool for MAN1B1-CDG patients.使用内切糖苷酶 H 作为 MAN1B1-CDG 患者的诊断工具。
Electrophoresis. 2018 Dec;39(24):3133-3141. doi: 10.1002/elps.201800020. Epub 2018 Aug 2.
8
Complementarity of electrophoretic, mass spectrometric, and gene sequencing techniques for the diagnosis and characterization of congenital disorders of glycosylation.电泳、质谱和基因测序技术在糖基化先天性疾病诊断和特征分析中的互补作用。
Electrophoresis. 2018 Dec;39(24):3123-3132. doi: 10.1002/elps.201800021. Epub 2018 Jul 3.
9
Two-dimensional electrophoresis highlights haptoglobin beta chain as an additional biomarker of congenital disorders of glycosylation.二维电泳将触珠蛋白β链凸显为糖基化先天性疾病的一种额外生物标志物。
Clin Chim Acta. 2017 Jul;470:70-74. doi: 10.1016/j.cca.2017.04.022. Epub 2017 Apr 27.

SLC37A4-CDG:一种新兴的伴发严重凝血障碍的糖基化先天性疾病的新生化见解。

SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy.

机构信息

AP-HP, Biochimie Métabolique et Cellulaire, Hôpital Bichat-Claude Bernard, Paris, France.

INSERM UMR1193, Université Paris-Saclay, 92290 Châtenay-Malabry, France.

出版信息

Clin Chim Acta. 2021 Oct;521:104-106. doi: 10.1016/j.cca.2021.07.005. Epub 2021 Jul 8.

DOI:10.1016/j.cca.2021.07.005
PMID:34245688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9119027/
Abstract

SLC37A4-CDG is an emerging congenital disorder of glycosylation which is characterized by a dominant inheritance and a major coagulopathy originating from the liver. Recent studies took interest in the biochemical alterations found in this CDG and showed that they consisted of multiple glycosylation abnormalities, which result from mislocalization of the endoplasmic reticulum glucose-6-phosphate transporter and associated Golgi homeostasis defects. In this work, we highlight in six affected individuals abnormal patterns for various serum N-glycoproteins and bikunin proteoglycan isoforms, together with specific alterations of the mass spectra of endoglycosidase H-released serum N-glycans. Collectively, these data complement previous findings, help to better delineate SLC37A4-CDG and could present interest in diagnosing this disease.

摘要

SLC37A4-CDG 是一种新兴的伴显性遗传的先天性糖基化缺陷疾病,其特征为以肝脏来源的严重凝血功能障碍。最近的研究对该疾病的生化改变产生了兴趣,发现其包含多种糖基化异常,这是由于内质网葡萄糖-6-磷酸转运蛋白的定位错误和相关高尔基体稳态缺陷所致。在这项工作中,我们在 6 名受影响个体中强调了各种血清 N-糖蛋白和 bikunin 蛋白聚糖同工型的异常模式,以及内切糖苷酶 H 释放的血清 N-糖链的质谱的特定改变。总的来说,这些数据补充了之前的发现,有助于更好地区分 SLC37A4-CDG,并可能有助于该疾病的诊断。